About N-[(1R)-1-cyclopropylethyl]-2-[(5-phenyl-1,3-oxazol-2-yl)sulfanyl]acetamide
N-[(1R)-1-cyclopropylethyl]-2-[(5-phenyl-1,3-oxazol-2-yl)sulfanyl]acetamide (PubChem CID 94799042) has the molecular formula C16H18N2O2S
and a molecular weight of 302.40 g/mol. Its IUPAC name is N-[(1R)-1-cyclopropylethyl]-2-[(5-phenyl-1,3-oxazol-2-yl)sulfanyl]acetamide.
Analyze N-[(1R)-1-cyclopropylethyl]-2-[(5-phenyl-1,3-oxazol-2-yl)sulfanyl]acetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[(1R)-1-cyclopropylethyl]-2-[(5-phenyl-1,3-oxazol-2-yl)sulfanyl]acetamide?
The IUPAC name of N-[(1R)-1-cyclopropylethyl]-2-[(5-phenyl-1,3-oxazol-2-yl)sulfanyl]acetamide (CID 94799042) is N-[(1R)-1-cyclopropylethyl]-2-[(5-phenyl-1,3-oxazol-2-yl)sulfanyl]acetamide.
What is the SMILES notation for N-[(1R)-1-cyclopropylethyl]-2-[(5-phenyl-1,3-oxazol-2-yl)sulfanyl]acetamide?
The canonical SMILES for N-[(1R)-1-cyclopropylethyl]-2-[(5-phenyl-1,3-oxazol-2-yl)sulfanyl]acetamide is C[C@@H](NC(=O)CSc1ncc(-c2ccccc2)o1)C1CC1.
What is the InChIKey of N-[(1R)-1-cyclopropylethyl]-2-[(5-phenyl-1,3-oxazol-2-yl)sulfanyl]acetamide?
The InChIKey is WCRONFVYNVGMHC-LLVKDONJSA-N. The full InChI is InChI=1S/C16H18N2O2S/c1-11(12-7-8-12)18-15(19)10-21-16-17-9-14(20-16)13-5-3-2-4-6-13/h2-6,9,11-12H,7-8,10H2,1H3,(H,18,19)/t11-/m1/s1.
What are the key properties of N-[(1R)-1-cyclopropylethyl]-2-[(5-phenyl-1,3-oxazol-2-yl)sulfanyl]acetamide?
N-[(1R)-1-cyclopropylethyl]-2-[(5-phenyl-1,3-oxazol-2-yl)sulfanyl]acetamide has a molecular weight of 302.40 g/mol, XLogP of 3.35, 6 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1R)-1-cyclopropylethyl]-2-[(5-phenyl-1,3-oxazol-2-yl)sulfanyl]acetamide is sourced from PubChem (CID 94799042), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).